These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7684858)

  • 21. Carcinoma of unknown primary origin: on the cusp of a new era.
    Raber MN
    Cancer J; 2010; 16(1):66-7. PubMed ID: 20164693
    [No Abstract]   [Full Text] [Related]  

  • 22. Empiric chemotherapy in patients with carcinoma of unknown primary site.
    Sporn JR; Greenberg BR
    Am J Med; 1990 Jan; 88(1):49-55. PubMed ID: 2403756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unknown primary tumors: is there a future therapeutic role for immune checkpoint inhibitors?
    Kourie HR; Awada G; Awada AH
    Future Oncol; 2016 Feb; 12(4):429-31. PubMed ID: 26776661
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of cancer from an unknown primary.
    Armstrong AC; Blackhall FH
    Expert Opin Pharmacother; 2007 Mar; 8(4):445-55. PubMed ID: 17309339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of metastatic adenocarcinoma of unknown primary in a pediatric patient: Opportunities for precision medicine.
    Prensner JR; Putra J; Vargas SO; Church AJ; Janeway KA; McCleary NJ; DuBois SG
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28780. PubMed ID: 33314665
    [No Abstract]   [Full Text] [Related]  

  • 26. Prognostic stratification in UPC: a role for assessing the value of conventional-dose and high-dose chemotherapy for unknown primary carcinoma.
    Saad ED; Abbruzzese JL
    Crit Rev Oncol Hematol; 2002 Feb; 41(2):205-11. PubMed ID: 11856596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinoma of unknown primary site.
    Greco FA; Hainsworth JD
    Ann Oncol; 1990; 1(2):98-9. PubMed ID: 2078498
    [No Abstract]   [Full Text] [Related]  

  • 28. Patients with unknown primaries face unusual insurance problems.
    Reynolds T
    J Natl Cancer Inst; 1998 Feb; 90(4):269. PubMed ID: 9486810
    [No Abstract]   [Full Text] [Related]  

  • 29. Chasing the unknown primary.
    Br Med J; 1980 Nov; 281(6250):1232. PubMed ID: 7427648
    [No Abstract]   [Full Text] [Related]  

  • 30. Palliative Care Was not Considered.
    Thöns M
    Dtsch Arztebl Int; 2018 May; 115(20-21):354. PubMed ID: 29914616
    [No Abstract]   [Full Text] [Related]  

  • 31. Uncertainty and the unmet informational needs of patients with cancer of unknown primary (CUP): a cross-sectional multi-site study.
    Guccione L; Fisher K; Mileshkin L; Tothill R; Bowtell D; Quinn S; DeFazio A; Karapetis CS; Wilcken N; Singh M; Steer C; Gao B; Warren M; Collins IM; Karanth N; Bryant C; Schofield P
    Support Care Cancer; 2022 Oct; 30(10):8217-8229. PubMed ID: 35804177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ECOG is as independent predictor of the response to chemotherapy, overall survival and progression-free survival in carcinoma of unknown primary site.
    Grajales-Álvarez R; Martin-Aguilar A; Silva JA; De La Garza-Salazar JG; Ruiz-García E; López-Camarillo C; Marchat LA; La Vega HA
    Mol Clin Oncol; 2017 May; 6(5):643-650. PubMed ID: 28515916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase II study of cisplatin /S-1 in patients with carcinomas of unknown primary site.
    Tsuya A; Kurata T; Tamiya A; Okamoto I; Ueda S; Sakai D; Sugimoto N; Matsumoto K; Goto I; Yamamoto N; Fukuoka M; Nakagawa K
    Invest New Drugs; 2013 Dec; 31(6):1568-72. PubMed ID: 23975509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is preoperative histological diagnosis necessary before referral to major surgery for cholangiocarcinoma?
    Buc E; Lesurtel M; Belghiti J
    HPB (Oxford); 2008; 10(2):98-105. PubMed ID: 18773064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables.
    Ponce Lorenzo J; Segura Huerta A; Díaz Beveridge R; Giménez Ortiz A; Aparisi Aparisi F; Fleitas Kanonnikoff T; Richart Aznar P; de la Cueva Sapiña H; Montalar Salcedo J
    Clin Transl Oncol; 2007 Jul; 9(7):452-8. PubMed ID: 17652059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gemcitabine and carboplatin in carcinoma of unknown primary site: a phase 2 Adelaide Cancer Trials and Education Collaborative study.
    Pittman KB; Olver IN; Koczwara B; Kotasek D; Patterson WK; Keefe DM; Karapetis CS; Parnis FX; Moldovan S; Yeend SJ; Price TJ;
    Br J Cancer; 2006 Nov; 95(10):1309-13. PubMed ID: 17088914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenocarcinoma of unknown primary site.
    Song SY; Kim WS; Lee HR; Jung HS; Oh SY; Kim JH; Kim K; Nam EM; Oh YR; Jung CW; Yoon SS; Im YH; Lee HG; Kang WK; Park CH; Park K
    Korean J Intern Med; 2002 Dec; 17(4):234-9. PubMed ID: 12647637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicentre phase II study of carboplatin and prolonged oral etoposide in the treatment of cancer of unknown primary site (CUPS).
    Warner E; Goel R; Chang J; Chow W; Verma S; Dancey J; Franssen E; Dulude H; Girouard M; Correia J; Gallant G
    Br J Cancer; 1998 Jun; 77(12):2376-80. PubMed ID: 9649162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenocarcinoma of unknown primary: retrospective analysis of chemosensitivity of 313 freshly explanted tumors in a tumor cloning system.
    Hanauske AR; Clark GM; Von Hoff DD
    Invest New Drugs; 1995; 13(1):43-9. PubMed ID: 7499107
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.